Alphanova Sterile 0.15% Brimonidine Tartarate Ophthalmic Solution

BRAND NAME: Alphanova 0.15% Ophthalmic Solution

ABOUT THE PRODUCT: Alphanova 0.15% is a specialized ophthalmic solution designed to support ocular health by effectively managing intraocular pressure. Containing the active ingredient Brimonidine Tartrate, this solution works through a dual-action mechanism to reduce the production of aqueous humor while simultaneously enhancing its drainage from the eye. It is an essential tool for those looking to maintain healthy eye pressure levels and protect their long-term vision under the guidance of a healthcare professional.

BENEFITS & KEY FEATURES:

• Dual Action Efficacy: The active formula reduces fluid production while boosting outflow to maintain optimal eye pressure.
• Proven Formulation: Contains 0.15% Brimonidine Tartrate, a trusted ingredient in ophthalmology for effective ocular care.
• Convenient Application: Designed for easy, precise, and sterile delivery when used as directed by your physician.

HOW TO USE SAFELY:

• Directions: Apply the solution exactly as prescribed by your doctor. When using, tilt your head back, gently pull down your lower eyelid, and carefully instill the required drops. Close your eyes for 2 to 3 minutes and gently press your finger against the inner corner of the eye to ensure maximum absorption. Always wait at least 5 minutes if you are using other eye medications.
• Important Tips: Avoid touching the dropper tip to any surface to prevent contamination. If you wear contact lenses, remove them before application and wait at least 15 minutes before reinserting them. Do not use the product if the solution becomes cloudy or changes color. Store the bottle at room temperature, away from direct heat, light, and reach of children.

SAFETY NOTE: Please consult your healthcare professional or physician before use. Do not self-medicate, and inform your doctor of any existing medical conditions or current medications, especially if you have cardiovascular concerns or are currently taking monoamine oxidase inhibitors.